1. 2554 Clinical outcome of initially metastatic hormone sensitive prostate cancer (HSPC) in real life population from a single center: Comparison with initially metastatic HSPC patients included in the GETUG-AFU 15 trial. (September 2015) Authors: Guerin, M.; Sfumato, P.; Boher, J.M.; Salem, N.; Dermeche, S.; Thomassin, J.; Fizazi, K.; Joly, F.; Oudard, S.; Habibian, M.; Culine, S.; Walz, J.; Gravis, G. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S494 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Designing phase II clinical trials to target subgroup of interest in a heterogeneous population: A case study using an R package. (1st September 2018) Authors: Cabarrou, B.; Sfumato, P.; Leconte, E.; Boher, J.M.; Filleron, T. Journal: Computers in biology and medicine Issue: Volume 100(2018) Page Start: 239 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Goftte: A R package for assessing goodness-of-fit in proportional (sub) distributions hazards regression models. (August 2019) Authors: Sfumato, P.; Filleron, T.; Giorgi, R.; Cook, R.J.; Boher, J.M. Journal: Computer methods and programs in biomedicine Issue: Volume 177(2019) Page Start: 269 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Impact of completion axillary lymph node dissection in patients with breast cancer and isolated tumour cells or micrometastases in sentinel nodes. (November 2016) Authors: Houvenaeghel, G.; Boher, J.M.; Reyal, F.; Cohen, M.; Garbay, J.R.; Classe, J.M.; Rouzier, R.; Giard, S.; Faure, C.; Charitansky, H.; Tunon de Lara, C.; Daraï, E.; Hudry, D.; Azuar, P.; Gimbergues, P.; Villet, R.; Sfumato, P.; Lambaudie, E. Journal: European journal of cancer Issue: Volume 67(2016) Page Start: 106 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Q-TWiST analysis of patients with metastatic castrate naive prostate cancer treated by androgen deprivation therapy with or without docetaxel in the randomised phase III GETUG-AFU 15 trial. (October 2017) Authors: Marino, P.; Sfumato, P.; Joly, F.; Fizazi, K.; Oudard, S.; Culine, S.; Habibian, M.; Boher, J.-M.; Gravis, G. Journal: European journal of cancer Issue: Volume 84(2017) Page Start: 27 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗